Scientists are cautiously excited about a new drug, which, in preliminary trials, destroyed the protein plaque that build up in the brain of Alzheimer’s patients. The drug, aducanumab, when taken in large doses was shown to be beneficial for patients who are in the earliest stages of the disease.
